608 JOURNAL OF COSMETIC SCIENCE
the importance of microbiome rebalancing. Explanations, visuals, and figures can be
extracted from these cutting-edge scientific advancements. In fact, the personal care
industry would benefit from leveraging the successful marketing strategies of the gut
microbiome sector. Consumers are already familiar with the term “probiotic.” It is time
to take the foundation a step further and demonstrate that rebalancing the microbiome
is not only vital for gut health but also essential for addressing a wide variety of skin
concerns.
Consumers in the future will be able to get a reading of their microbiome profile, and
perhaps the future holds products with specifically tailored microbiome benefits. Only
time will tell which brands will pioneer this space with effective enough communication
for consumers to start listening.
REFERENCES
(1) Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin
axis. Front Microbiol. 2018 9:1459. doi:10.3389/fmicb.2018.01459
(2) Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab.
2009 10(1):68–78. doi:10.2174/138920009787048437
(3) De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut–skin axis: current
knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms.
2021 9(2):353. doi:10.3390/microorganisms9020353
(4) Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 April 9(4):244–253. doi:10.1038/
nrmicro2537. Erratum in: Nat Rev Microbiol. 2011 August 9(4):244–253. doi:10.1038/nrmicro2537.
(5) Callewaert C, Knödlseder N, Karoglan A, Güell M, Paetzold B. Skin microbiome transplantation
and manipulation: current state of the art. Comput Struct Biotechnol J. 2021 January 4 19:624–631.
doi:10.1016/j.csbj.2021.01.001
(6) Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol.
2000 18(1):767–811. doi:10.1146/annurev.immunol.18.1.767
(7) Roghanian A. Dendritic Cells. British Society for Immunology.
(8) Liu K. Dendritic cells. Encyclopedia of Cell Biology. 2016:741–749. Epub August 20, 2015.
(9) Alberts B. T cells and MHC proteins. Molecular Biology of the Cell. 4th ed. United States National Library
of Medicine. January 1, 1970.
(10) Pérez-Cobas AE, Gomez-Valero L, Buchrieser C. Metagenomic approaches in microbial ecology: an update
on whole- genome and marker gene sequencing analyses. Microb Genom. 2020 August 6(8):mgen000409.
doi:10.1099/mgen.0.000409. Epub July 24, 2020.
(11) Chen Y, Fan L-C, Chai Y-H, Xu J-F. Advantages and challenges of metagenomic sequencing for the
diagnosis of pulmonary infectious diseases. Clin Respir J. 2022 October 16(10):646–656. doi:10.1111/
crj.13538. Epub September 6, 2022.
(12) Pérez-Losada M, Narayanan DB, Kolbe AR, et al. Comparative analysis of metagenomics and
metataxonomics for the characterization of vermicompost microbiomes. Front Microbiol. 2022 May
10 13:854423. doi:10.3389/fmicb.2022.854423
(13) Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics:
methods, interpretation, clinical relevance. Pathogens. 2021 10(2):165. doi:10.3390/pathogens10020165
(14) Giuliano C, Patel CR, Kale-Pradhan PB. A guide to bacterial culture identification and results
interpretation. P T. 2019 April 44(4):192–200.
(15) Ceri H, Olson M, Morck D, et al. The MBEC assay system: multiple equivalent biofilms for antibiotic
and biocide susceptibility testing. Methods Enzymol. Academic Press. 2001 337:377–385. doi:10.1016/
s0076-6879(01)37026-x
the importance of microbiome rebalancing. Explanations, visuals, and figures can be
extracted from these cutting-edge scientific advancements. In fact, the personal care
industry would benefit from leveraging the successful marketing strategies of the gut
microbiome sector. Consumers are already familiar with the term “probiotic.” It is time
to take the foundation a step further and demonstrate that rebalancing the microbiome
is not only vital for gut health but also essential for addressing a wide variety of skin
concerns.
Consumers in the future will be able to get a reading of their microbiome profile, and
perhaps the future holds products with specifically tailored microbiome benefits. Only
time will tell which brands will pioneer this space with effective enough communication
for consumers to start listening.
REFERENCES
(1) Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin
axis. Front Microbiol. 2018 9:1459. doi:10.3389/fmicb.2018.01459
(2) Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health. Curr Drug Metab.
2009 10(1):68–78. doi:10.2174/138920009787048437
(3) De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut–skin axis: current
knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms.
2021 9(2):353. doi:10.3390/microorganisms9020353
(4) Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 April 9(4):244–253. doi:10.1038/
nrmicro2537. Erratum in: Nat Rev Microbiol. 2011 August 9(4):244–253. doi:10.1038/nrmicro2537.
(5) Callewaert C, Knödlseder N, Karoglan A, Güell M, Paetzold B. Skin microbiome transplantation
and manipulation: current state of the art. Comput Struct Biotechnol J. 2021 January 4 19:624–631.
doi:10.1016/j.csbj.2021.01.001
(6) Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol.
2000 18(1):767–811. doi:10.1146/annurev.immunol.18.1.767
(7) Roghanian A. Dendritic Cells. British Society for Immunology.
(8) Liu K. Dendritic cells. Encyclopedia of Cell Biology. 2016:741–749. Epub August 20, 2015.
(9) Alberts B. T cells and MHC proteins. Molecular Biology of the Cell. 4th ed. United States National Library
of Medicine. January 1, 1970.
(10) Pérez-Cobas AE, Gomez-Valero L, Buchrieser C. Metagenomic approaches in microbial ecology: an update
on whole- genome and marker gene sequencing analyses. Microb Genom. 2020 August 6(8):mgen000409.
doi:10.1099/mgen.0.000409. Epub July 24, 2020.
(11) Chen Y, Fan L-C, Chai Y-H, Xu J-F. Advantages and challenges of metagenomic sequencing for the
diagnosis of pulmonary infectious diseases. Clin Respir J. 2022 October 16(10):646–656. doi:10.1111/
crj.13538. Epub September 6, 2022.
(12) Pérez-Losada M, Narayanan DB, Kolbe AR, et al. Comparative analysis of metagenomics and
metataxonomics for the characterization of vermicompost microbiomes. Front Microbiol. 2022 May
10 13:854423. doi:10.3389/fmicb.2022.854423
(13) Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics:
methods, interpretation, clinical relevance. Pathogens. 2021 10(2):165. doi:10.3390/pathogens10020165
(14) Giuliano C, Patel CR, Kale-Pradhan PB. A guide to bacterial culture identification and results
interpretation. P T. 2019 April 44(4):192–200.
(15) Ceri H, Olson M, Morck D, et al. The MBEC assay system: multiple equivalent biofilms for antibiotic
and biocide susceptibility testing. Methods Enzymol. Academic Press. 2001 337:377–385. doi:10.1016/
s0076-6879(01)37026-x
